NCT07263451 Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study Status RECRUITING Phase NA
NCT07262099 Study of Effects of Dao-yin Exercise on the Patients With Breast Cancer Post Operation and Receiving Adjuvant Chemotherapy Status COMPLETED Phase NA
NCT07258108 Sac-TMT Plus KL-A167 in PD-L1+, HR+/HER2- Metastatic Breast Cancer After CDK4/6 Inhibitors Status RECRUITING Phase PHASE2
NCT07257484 Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors Status NOT_YET_RECRUITING Phase PHASE4
NCT07257003 A Nationwide Multicenter, Single-arm, Retrospective Study of Delayed Endoscopic DTI-BR After Simple Mastectomy Status NOT_YET_RECRUITING Phase NA
NCT07255612 Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer) Status NOT_YET_RECRUITING Phase PHASE2
NCT07254221 Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients Status NOT_YET_RECRUITING Phase PHASE4
NCT07252986 Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence Status RECRUITING Phase N/A
NCT07251868 Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study Status RECRUITING Phase N/A
NCT07250386 A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07250204 A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation. Status NOT_YET_RECRUITING Phase N/A
NCT07246317 Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07245797 A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Inavolisib Plus Pertuzumab and Trastuzumab as Subcutaneous (PH-FDC SC) and 3-week Cycle Nab-paclitaxel for PIK3CA-mutated, HER2+, eBC Status NOT_YET_RECRUITING Phase PHASE2
NCT07245069 Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients Status RECRUITING Phase PHASE2
NCT07244094 A Study on Predicting the Risk of Distant Metastasis in Breast Cancer Using AI-Generated Spatial Pathological Maps Status RECRUITING Phase N/A
NCT07243418 Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study Status NOT_YET_RECRUITING Phase PHASE2